0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Pain Treatment Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-38X7904
Home | Market Reports | Health| Health Conditions| Pain Management
Global Chronic Pain Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Chronic Pain Treatment Market Research Report 2023

Code: QYRE-Auto-38X7904
Report
March 2023
Pages:88
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Chronic Pain Treatment Market

The global Chronic Pain Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Chronic Pain Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Chronic Pain Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Chronic Pain Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Chronic Pain Treatment include Eli Lilly and Company, GlaxoSmithKline, Pfizer, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Novartis AG, Johnson & Johnson and AstraZeneca PLC, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Treatment.
The Chronic Pain Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chronic Pain Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Eli Lilly and Company
  • GlaxoSmithKline
  • Pfizer
  • Medtronic
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • Becton, Dickinson and Company
  • Sanofi

Segment by Type

  • Drugs
  • Devices

Segment by Application

  • Hospitals
  • Clinics
  • Nursing Homes
  • Research Centers

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chronic Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Chronic Pain Treatment Market Report

Report MetricDetails
Report NameGlobal Chronic Pain Treatment Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drugs
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Chronic Pain Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Nursing Homes
1.3.5 Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Treatment Market Perspective (2018-2029)
2.2 Chronic Pain Treatment Growth Trends by Region
2.2.1 Global Chronic Pain Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chronic Pain Treatment Historic Market Size by Region (2018-2023)
2.2.3 Chronic Pain Treatment Forecasted Market Size by Region (2024-2029)
2.3 Chronic Pain Treatment Market Dynamics
2.3.1 Chronic Pain Treatment Industry Trends
2.3.2 Chronic Pain Treatment Market Drivers
2.3.3 Chronic Pain Treatment Market Challenges
2.3.4 Chronic Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Treatment Players by Revenue
3.1.1 Global Top Chronic Pain Treatment Players by Revenue (2018-2023)
3.1.2 Global Chronic Pain Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Pain Treatment Revenue
3.4 Global Chronic Pain Treatment Market Concentration Ratio
3.4.1 Global Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Treatment Revenue in 2022
3.5 Chronic Pain Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Pain Treatment Product Solution and Service
3.7 Date of Enter into Chronic Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Treatment Breakdown Data by Type
4.1 Global Chronic Pain Treatment Historic Market Size by Type (2018-2023)
4.2 Global Chronic Pain Treatment Forecasted Market Size by Type (2024-2029)
5 Chronic Pain Treatment Breakdown Data by Application
5.1 Global Chronic Pain Treatment Historic Market Size by Application (2018-2023)
5.2 Global Chronic Pain Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chronic Pain Treatment Market Size (2018-2029)
6.2 North America Chronic Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chronic Pain Treatment Market Size by Country (2018-2023)
6.4 North America Chronic Pain Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Treatment Market Size (2018-2029)
7.2 Europe Chronic Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chronic Pain Treatment Market Size by Country (2018-2023)
7.4 Europe Chronic Pain Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Treatment Market Size (2018-2029)
8.2 Asia-Pacific Chronic Pain Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chronic Pain Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Pain Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Treatment Market Size (2018-2029)
9.2 Latin America Chronic Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chronic Pain Treatment Market Size by Country (2018-2023)
9.4 Latin America Chronic Pain Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Treatment Market Size (2018-2029)
10.2 Middle East & Africa Chronic Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chronic Pain Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Pain Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Chronic Pain Treatment Introduction
11.1.4 Eli Lilly and Company Revenue in Chronic Pain Treatment Business (2018-2023)
11.1.5 Eli Lilly and Company Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Chronic Pain Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Chronic Pain Treatment Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Chronic Pain Treatment Introduction
11.3.4 Pfizer Revenue in Chronic Pain Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Chronic Pain Treatment Introduction
11.4.4 Medtronic Revenue in Chronic Pain Treatment Business (2018-2023)
11.4.5 Medtronic Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Chronic Pain Treatment Introduction
11.5.4 Abbott Laboratories Revenue in Chronic Pain Treatment Business (2018-2023)
11.5.5 Abbott Laboratories Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Chronic Pain Treatment Introduction
11.6.4 Boston Scientific Corporation Revenue in Chronic Pain Treatment Business (2018-2023)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Chronic Pain Treatment Introduction
11.7.4 Novartis AG Revenue in Chronic Pain Treatment Business (2018-2023)
11.7.5 Novartis AG Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Pain Treatment Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Pain Treatment Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Detail
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Chronic Pain Treatment Introduction
11.9.4 AstraZeneca PLC Revenue in Chronic Pain Treatment Business (2018-2023)
11.9.5 AstraZeneca PLC Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Chronic Pain Treatment Introduction
11.10.4 Bristol-Myers Squibb Revenue in Chronic Pain Treatment Business (2018-2023)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Becton, Dickinson and Company
11.11.1 Becton, Dickinson and Company Company Detail
11.11.2 Becton, Dickinson and Company Business Overview
11.11.3 Becton, Dickinson and Company Chronic Pain Treatment Introduction
11.11.4 Becton, Dickinson and Company Revenue in Chronic Pain Treatment Business (2018-2023)
11.11.5 Becton, Dickinson and Company Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Chronic Pain Treatment Introduction
11.12.4 Sanofi Revenue in Chronic Pain Treatment Business (2018-2023)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Drugs
    Table 3. Key Players of Devices
    Table 4. Global Chronic Pain Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Chronic Pain Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Chronic Pain Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Chronic Pain Treatment Market Share by Region (2018-2023)
    Table 8. Global Chronic Pain Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Chronic Pain Treatment Market Share by Region (2024-2029)
    Table 10. Chronic Pain Treatment Market Trends
    Table 11. Chronic Pain Treatment Market Drivers
    Table 12. Chronic Pain Treatment Market Challenges
    Table 13. Chronic Pain Treatment Market Restraints
    Table 14. Global Chronic Pain Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Chronic Pain Treatment Market Share by Players (2018-2023)
    Table 16. Global Top Chronic Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Treatment as of 2022)
    Table 17. Ranking of Global Top Chronic Pain Treatment Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Chronic Pain Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chronic Pain Treatment Product Solution and Service
    Table 21. Date of Enter into Chronic Pain Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chronic Pain Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Chronic Pain Treatment Revenue Market Share by Type (2018-2023)
    Table 25. Global Chronic Pain Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Chronic Pain Treatment Revenue Market Share by Type (2024-2029)
    Table 27. Global Chronic Pain Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Chronic Pain Treatment Revenue Market Share by Application (2018-2023)
    Table 29. Global Chronic Pain Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Chronic Pain Treatment Revenue Market Share by Application (2024-2029)
    Table 31. North America Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Chronic Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Chronic Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Chronic Pain Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Chronic Pain Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Chronic Pain Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Chronic Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Chronic Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Chronic Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Eli Lilly and Company Company Detail
    Table 47. Eli Lilly and Company Business Overview
    Table 48. Eli Lilly and Company Chronic Pain Treatment Product
    Table 49. Eli Lilly and Company Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 50. Eli Lilly and Company Recent Development
    Table 51. GlaxoSmithKline Company Detail
    Table 52. GlaxoSmithKline Business Overview
    Table 53. GlaxoSmithKline Chronic Pain Treatment Product
    Table 54. GlaxoSmithKline Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 55. GlaxoSmithKline Recent Development
    Table 56. Pfizer Company Detail
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Chronic Pain Treatment Product
    Table 59. Pfizer Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. Medtronic Company Detail
    Table 62. Medtronic Business Overview
    Table 63. Medtronic Chronic Pain Treatment Product
    Table 64. Medtronic Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 65. Medtronic Recent Development
    Table 66. Abbott Laboratories Company Detail
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Chronic Pain Treatment Product
    Table 69. Abbott Laboratories Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 70. Abbott Laboratories Recent Development
    Table 71. Boston Scientific Corporation Company Detail
    Table 72. Boston Scientific Corporation Business Overview
    Table 73. Boston Scientific Corporation Chronic Pain Treatment Product
    Table 74. Boston Scientific Corporation Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 75. Boston Scientific Corporation Recent Development
    Table 76. Novartis AG Company Detail
    Table 77. Novartis AG Business Overview
    Table 78. Novartis AG Chronic Pain Treatment Product
    Table 79. Novartis AG Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 80. Novartis AG Recent Development
    Table 81. Johnson & Johnson Company Detail
    Table 82. Johnson & Johnson Business Overview
    Table 83. Johnson & Johnson Chronic Pain Treatment Product
    Table 84. Johnson & Johnson Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 85. Johnson & Johnson Recent Development
    Table 86. AstraZeneca PLC Company Detail
    Table 87. AstraZeneca PLC Business Overview
    Table 88. AstraZeneca PLC Chronic Pain Treatment Product
    Table 89. AstraZeneca PLC Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 90. AstraZeneca PLC Recent Development
    Table 91. Bristol-Myers Squibb Company Detail
    Table 92. Bristol-Myers Squibb Business Overview
    Table 93. Bristol-Myers Squibb Chronic Pain Treatment Product
    Table 94. Bristol-Myers Squibb Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 95. Bristol-Myers Squibb Recent Development
    Table 96. Becton, Dickinson and Company Company Detail
    Table 97. Becton, Dickinson and Company Business Overview
    Table 98. Becton, Dickinson and Company Chronic Pain Treatment Product
    Table 99. Becton, Dickinson and Company Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 100. Becton, Dickinson and Company Recent Development
    Table 101. Sanofi Company Detail
    Table 102. Sanofi Business Overview
    Table 103. Sanofi Chronic Pain Treatment Product
    Table 104. Sanofi Revenue in Chronic Pain Treatment Business (2018-2023) & (US$ Million)
    Table 105. Sanofi Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Pain Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Chronic Pain Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Drugs Features
    Figure 4. Devices Features
    Figure 5. Global Chronic Pain Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Chronic Pain Treatment Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Nursing Homes Case Studies
    Figure 10. Research Centers Case Studies
    Figure 11. Chronic Pain Treatment Report Years Considered
    Figure 12. Global Chronic Pain Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Chronic Pain Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Chronic Pain Treatment Market Share by Region: 2022 VS 2029
    Figure 15. Global Chronic Pain Treatment Market Share by Players in 2022
    Figure 16. Global Top Chronic Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Treatment as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Chronic Pain Treatment Revenue in 2022
    Figure 18. North America Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Chronic Pain Treatment Market Share by Country (2018-2029)
    Figure 20. United States Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Chronic Pain Treatment Market Share by Country (2018-2029)
    Figure 24. Germany Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Chronic Pain Treatment Market Share by Region (2018-2029)
    Figure 32. China Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Chronic Pain Treatment Market Share by Country (2018-2029)
    Figure 40. Mexico Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Chronic Pain Treatment Market Share by Country (2018-2029)
    Figure 44. Turkey Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Chronic Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Eli Lilly and Company Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 48. Pfizer Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 49. Medtronic Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 50. Abbott Laboratories Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 51. Boston Scientific Corporation Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 52. Novartis AG Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 53. Johnson & Johnson Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 54. AstraZeneca PLC Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 56. Becton, Dickinson and Company Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 57. Sanofi Revenue Growth Rate in Chronic Pain Treatment Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Paracetamol Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-30W8975
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Painkiller Drug Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-35Q15235
Fri Sep 22 00:00:00 UTC 2023

Add to Cart

Global Neuropathy Pain Treatment Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-17O331
Fri Sep 22 00:00:00 UTC 2023

Add to Cart

Global Human Pain Management Drug Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-0T15701
Fri Sep 22 00:00:00 UTC 2023

Add to Cart